Oculis Holding AGOCSNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P31
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -5.31% |
| Q2 2025 | 0.93% |
| Q1 2025 | 25.57% |
| Q4 2024 | -9.51% |
| Q3 2024 | -21.05% |
| Q2 2024 | 51.67% |
| Q1 2024 | 35.21% |
| Q4 2023 | -9.50% |
| Q3 2023 | 43.14% |
| Q2 2023 | 0.81% |
| Q1 2023 | -10.76% |
| Q4 2022 | 50.02% |
| Q3 2022 | -31.48% |
| Q2 2022 | 24.77% |
| Q1 2022 | 52.21% |
| Q4 2021 | 98.48% |
| Q3 2021 | 0.00% |